N-oleoylethanolamine − phosphatidylcholine complex loaded, DSPE-PEG integrated liposomes for efficient stroke

References

• Ballarin B, Tymianski M. (2018). Discovery and development of NA-1 for the treatment of acute ischemic stroke. Acta Pharmacol Sin 39:661–8.
   PubMed Web of Science ®Google Scholar
• Bao QQ, Hu P, Xu YY, et al. (2018). Simultaneous blood-brain barrier crossing and protection for stroke treatment based on edaravone-loaded ceria nanoparticles. ACS Nano 12:6794–805.
   PubMed Web of Science ®Google Scholar
• Campbell BCV, De Silva DA, Macleod MR, et al. (2019). Ischaemic stroke. Nat Rev Dis Primers 5:70.
   PubMed Web of Science ®Google Scholar
• Chen C, Li T, Zhao Y, et al. (2018). Platelet glycoprotein receptor Ib blockade ameliorates experimental cerebral ischemia-reperfusion injury by strengthening the blood-brain barrier function and anti-thrombo-inflammatory property. Brain Behav Immun 69:255–63.
   PubMed Web of Science ®Google Scholar
• Dirnagl U, Iadecola C, Moskowitz MA. (1999). Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22:391–7.
   PubMed Web of Science ®Google Scholar
• Forrester SJ, Kikuchi DS, Hernandes MS, et al. (2018). Reactive oxygen species in metabolic and inflammatory signaling. Circ Res 122:877–902.
   PubMed Web of Science ®Google Scholar
• Gilgun-Sherki Y, Rosenbaum Z, Melamed E, Offen D. (2002). Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev 54:271–84.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Nieto D, Fernandez-Serra R, Perez-Rigueiro J, et al. (2020). Biomaterials to neuroprotect the stroke brain: a large opportunity for narrow time windows. Cells 9:1074.
   PubMed Web of Science ®Google Scholar
• Howells DW, Porritt MJ, Rewell SSJ, et al. (2010). Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J Cereb Blood Flow Metab 30:1412–31.
   PubMed Web of Science ®Google Scholar
• Lee GA, Lin TN, Chen CY, et al. (2018). Interleukin 15 blockade protects the brain from cerebral ischemia-reperfusion injury. Brain Behav Immun 73:562–70.
   PubMed Web of Science ®Google Scholar
• Luo D, Zhang Y, Yuan X, et al. (2019). Oleoylethanolamide inhibits glial activation via moudulating PPARα and promotes motor function recovery after brain ischemia. Pharmacol Res 141:530–40.
   PubMed Web of Science ®Google Scholar
• Nakamura K, Shichita T. (2019). Cellular and molecular mechanisms of sterile inflammation in ischaemic stroke. J Biochem 165:459–64.
   PubMed Web of Science ®Google Scholar
• Peng X, Jing P, Chen J, Xu L. (2019). The role of circular RNA HECTD1 expression in disease risk, disease severity, inflammation, and recurrence of acute ischemic stroke. J Clin Lab Anal 33:e22954.
   PubMed Web of Science ®Google Scholar
• Powers WJ, Rabinstein AA, Ackerson T, et al. (2018). 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke 49:e46–E110.
   PubMed Web of Science ®Google Scholar
• Rawlinson C, Jenkins S, Thei L, et al. (2020). Post-ischaemic immunological response in the brain: targeting microglia in ischaemic stroke therapy. Brain Sci 10:159.
   PubMed Web of Science ®Google Scholar
• Savitz SI, Baron JC, Yenari MA, et al. (2017). Reconsidering neuroprotection in the reperfusion era. Stroke 48:3413–9.
   PubMed Web of Science ®Google Scholar
• Shi KB, Tian DC, Li ZLG, et al. (2019). Global brain inflammation in stroke. Lancet Neurol 18:1058–66.
   PubMed Web of Science ®Google Scholar
• Sommer CJ. (2017). Ischemic stroke: experimental models and reality. Acta Neuropathol 133:245–61.
   PubMed Web of Science ®Google Scholar
• Stoll G, Nieswandt B. (2019). Thrombo-inflammation in acute ischaemic stroke - implications for treatment. Nat Rev Neurol 15:473–81.
   PubMed Web of Science ®Google Scholar
• Valko M, Leibfritz D, Moncol J, et al. (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44–84.
   PubMed Web of Science ®Google Scholar
• Virani SS, Alonso A, Benjamin EJ, et al. (2020). Heart disease and stroke statistics-2020 update: a report from the American heart association. Circulation 141:e139–e596.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary. J Am Coll Cardiol 71:2199–279.
   PubMed Web of Science ®Google Scholar
• Wimmer I, Zrzavy T, Lassmann H. (2018). Neuroinflammatory responses in experimental and human stroke lesions. J Neuroimmunol 323:10–8.
   PubMed Web of Science ®Google Scholar
• Wulff-Perez M, Pavon FJ, Martin-Rodriguez A, et al. (2014). Preparation, characterization and in vivo evaluation of nanoemulsions for the controlled delivery of the antiobesity agent N-oleoylethanolamine. Nanomedicine (Lond) 9:2761–72.
   PubMed Web of Science ®Google Scholar
• Yang L, Guo H, Li Y, et al. (2016). Oleoylethanolamide exerts anti-inflammatory effects on LPS-induced THP-1 cells by enhancing PPARα signaling and inhibiting the NF-κB and ERK1/2/AP-1/STAT3 pathways. Sci Rep 6:34611.
   PubMed Web of Science ®Google Scholar
• Yang LC, Guo H, Zhou H, et al. (2015). Chronic oleoylethanolamide treatment improves spatial cognitive deficits through enhancing hippocampal neurogenesis after transient focal cerebral ischemia. Biochem Pharmacol 94:270–81.
   PubMed Web of Science ®Google Scholar
• Yang X, Xu L, Zhou J, et al. (2019). Integration of phospholipid-complex nanocarrier assembly with endogenous N-oleoylethanolamine for efficient stroke therapy. J Nanobiotechnol 17:8.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Yanai H, Namiki Y, et al. (2006). Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev 12:9–20.
   PubMedGoogle Scholar
• Zhang N, Komine-Kobayashi M, Tanaka R, et al. (2005). Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal Ischemia in mice brain. Stroke 36:2220–5.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Liu YJ, Jing Z, et al. (2018). N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway. Biochem Biophys Res Commun 496:415–21.
   PubMed Web of Science ®Google Scholar
• Zhou H, Yang W-s, Li Y, et al. (2017). Oleoylethanolamide attenuates apoptosis by inhibiting the TLR4/NF-κB and ERK1/2 signaling pathways in mice with acute ischemic stroke. Naunyn Schmiedebergs Arch Pharmacol 390:77–84.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yang L, Ma A, et al. (2012). Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α. Neuropharmacology 63:242–9.
   PubMed Web of Science ®Google Scholar